News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,492 Results
Type
Article (46239)
Company Profile (303)
Press Release (687949)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (211901)
Career Advice (2548)
Deals (36981)
Drug Delivery (109)
Drug Development (84060)
Employer Resources (181)
FDA (16845)
Job Trends (15623)
News (359740)
Policy (34664)
Tag
Academia (2719)
Academic (1)
Accelerated approval (10)
Adcomms (24)
Allergies (102)
Alliances (52043)
ALS (115)
Alzheimer's disease (1488)
Antibody-drug conjugate (ADC) (165)
Approvals (16832)
Artificial intelligence (331)
Autoimmune disease (31)
Automation (19)
Bankruptcy (377)
Best Places to Work (11912)
BIOSECURE Act (20)
Biosimilars (131)
Biotechnology (190)
Bladder cancer (94)
Brain cancer (38)
Breast cancer (372)
Cancer (2949)
Cardiovascular disease (226)
Career advice (2118)
Career pathing (32)
CAR-T (190)
CDC (34)
Cell therapy (516)
Cervical cancer (22)
Clinical research (68903)
Collaboration (1061)
Company closure (3)
Compensation (701)
Complete response letters (30)
COVID-19 (2769)
CRISPR (66)
C-suite (341)
Cystic fibrosis (120)
Data (3047)
Decentralized trials (2)
Denatured (30)
Depression (65)
Diabetes (358)
Diagnostics (6595)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (143)
Drug pricing (139)
Drug shortages (32)
Duchenne muscular dystrophy (131)
Earnings (89448)
Editorial (45)
Employer branding (21)
Employer resources (156)
Events (117560)
Executive appointments (871)
FDA (18537)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (951)
Gene editing (143)
Generative AI (24)
Gene therapy (399)
GLP-1 (847)
Government (4768)
Grass and pollen (5)
Guidances (182)
Healthcare (19300)
HIV (41)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (160)
Immuno-oncology (11)
Indications (40)
Infectious disease (2946)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (123)
Interviews (471)
IPO (17028)
IRA (53)
Job creations (4108)
Job search strategy (1770)
Kidney cancer (13)
Labor market (54)
Layoffs (534)
Leadership (24)
Legal (8595)
Liver cancer (80)
Longevity (12)
Lung cancer (409)
Lymphoma (214)
Machine learning (11)
Management (63)
Manufacturing (410)
MASH (94)
Medical device (13707)
Medtech (13712)
Mergers & acquisitions (20674)
Metabolic disorders (892)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (125)
Neuropsychiatric disorders (36)
Neuroscience (2200)
NextGen: Class of 2025 (6794)
Non-profit (4631)
Now hiring (48)
Obesity (458)
Opinion (263)
Ovarian cancer (102)
Pain (120)
Pancreatic cancer (122)
Parkinson's disease (189)
Partnered (22)
Patents (314)
Patient recruitment (171)
Peanut (54)
People (60034)
Pharmaceutical (92)
Pharmacy benefit managers (24)
Phase I (21397)
Phase II (30312)
Phase III (22690)
Pipeline (1668)
Policy (221)
Postmarket research (2683)
Preclinical (9348)
Press Release (68)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (492)
Real estate (6313)
Recruiting (70)
Regulatory (23897)
Reports (51)
Research institute (2446)
Resumes & cover letters (419)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (94)
Series A (162)
Series B (111)
Service/supplier (13)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3788)
State (2)
Stomach cancer (15)
Supply chain (78)
Tariffs (65)
The Weekly (59)
Vaccines (833)
Venture capital (56)
Weight loss (289)
Women's health (47)
Worklife (19)
Date
Today (82)
Last 7 days (353)
Last 30 days (1839)
Last 365 days (31844)
2025 (17281)
2024 (36022)
2023 (40900)
2022 (52144)
2021 (56736)
2020 (55333)
2019 (48121)
2018 (36406)
2017 (33636)
2016 (33237)
2015 (39201)
2014 (33042)
2013 (28138)
2012 (30271)
2011 (30994)
2010 (28907)
Location
Africa (852)
Alabama (61)
Alaska (7)
Arizona (256)
Arkansas (14)
Asia (41895)
Australia (6791)
California (7530)
Canada (2390)
China (701)
Colorado (323)
Connecticut (322)
Delaware (197)
Europe (90093)
Florida (1131)
Georgia (250)
Hawaii (1)
Idaho (59)
Illinois (657)
India (28)
Indiana (371)
Iowa (18)
Japan (238)
Kansas (111)
Kentucky (30)
Louisiana (14)
Maine (73)
Maryland (1046)
Massachusetts (5633)
Michigan (263)
Minnesota (457)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2103)
New Mexico (29)
New York (2110)
North Carolina (1109)
North Dakota (9)
Northern California (3309)
Ohio (240)
Oklahoma (16)
Oregon (39)
Pennsylvania (1630)
Puerto Rico (17)
Rhode Island (36)
South America (1233)
South Carolina (35)
South Dakota (1)
Southern California (2811)
Tennessee (126)
Texas (1145)
United States (28042)
Utah (222)
Virginia (198)
Washington D.C. (72)
Washington State (645)
West Virginia (4)
Wisconsin (69)
734,492 Results for "ani pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
June 12, 2025
·
10 min read
Press Releases
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
May 27, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
July 3, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
March 19, 2025
·
6 min read
Press Releases
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
May 13, 2025
·
1 min read
BioMidwest
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex ® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
May 20, 2024
·
4 min read
Press Releases
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
May 12, 2025
·
27 min read
Press Releases
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
March 18, 2025
·
5 min read
Press Releases
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
May 22, 2025
·
12 min read
BioMidwest
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City.
May 29, 2024
·
1 min read
1 of 73,450
Next
